<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00592228</url>
  </required_header>
  <id_info>
    <org_study_id>H-0706-026-210</org_study_id>
    <nct_id>NCT00592228</nct_id>
  </id_info>
  <brief_title>Proper Fractional Flow Reserve Criteria for Intermediate Lesions in the Era of Drug-eluting Stent</brief_title>
  <acronym>DEFER-DES</acronym>
  <official_title>Deferral of Angioplasty According to Fractional Flow Reserve vs. Routine Drug-eluting Stent Implantation in Intermediate Coronary Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Angiographic evaluation for intermediate lesions is not always accurate. Fractional flow
      reserve-guided deferral strategy for these lesions showed the same event rate as routine
      intervention strategy. However, proper FFR criterion for these lesions in the era of
      drug-eluting stent is not known. This study sought to evaluate the clinical outcomes of
      intermediate lesions according to FFR and compare those of FFR-guided intervention with
      routine drug-eluting stent implantation strategy.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    due to slow enrollment
  </why_stopped>
  <start_date>January 2007</start_date>
  <completion_date type="Anticipated">January 2009</completion_date>
  <primary_completion_date type="Anticipated">January 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical event: Cardiac death, myocardial infarction, target lesion revascularization</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>IVUS</measure>
    <time_frame>at the time of procedure</time_frame>
    <description>IVUS minimum lumen area</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Coronary Angiography</condition>
  <condition>Drug-eluting Stents</condition>
  <condition>Fractional Flow Reserve, Myocardial</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Fractional flow guided drug-eluting stent implantation arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Routine drug-eluting stent implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cypher, Taxus or Endeavor</intervention_name>
    <description>percutaneous drug-eluting stent implantation,
FFR group: if FFR&lt;0.75
Routine DES group</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective PCI

          -  Angiographically intermediate stenosis (50-75% by visual estimation) in native major
             coronary arteries, proximal and mid (branch, distal lesion: exclusion)

          -  Reference diameter &gt; 2.5mm, lesion length &lt; 60mm (cover by 2 stents)

          -  No documented evidence of ischemia by noninvasive tests

        Exclusion Criteria:

          -  Acute ST elevation MI

          -  Left main disease

          -  Chronic renal failure (cr &gt;2 mg/dL)

          -  Expected survival &lt; 2yrs

          -  &gt; 1degree AV block
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bon-Kwon Koo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul national university hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2007</study_first_submitted>
  <study_first_submitted_qc>December 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2008</study_first_posted>
  <last_update_submitted>December 20, 2010</last_update_submitted>
  <last_update_submitted_qc>December 20, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2010</last_update_posted>
  <responsible_party>
    <name_title>Bon-Kwon Koo</name_title>
    <organization>Seoul National University Hospital</organization>
  </responsible_party>
  <keyword>intermediate lesion</keyword>
  <keyword>drug-eluting stent</keyword>
  <keyword>fractional flow reserve</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

